RUA Life Sciences (LON:RUA) Issues Quarterly Earnings Results

RUA Life Sciences (LON:RUA – Get Free Report) issued its earnings results on Tuesday. The company reported GBX (0.33) EPS for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%. The business had revenue of GBX 275 million for the quarter.

RUA Life Sciences Price Performance

Shares of LON:RUA opened at GBX 19.50 on Tuesday. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64. The firm has a market cap of £12.10 million, a price-to-earnings ratio of -2.61 and a beta of 0.96. The business has a 50-day simple moving average of GBX 19.90 and a two-hundred day simple moving average of GBX 15.84. RUA Life Sciences has a fifty-two week low of GBX 10.42 and a fifty-two week high of GBX 26.80.

Get RUA Life Sciences alerts:

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Recommended Stories

• Five stocks we like better than RUA Life Sciences
• Overclocking Qualcomm: Rewiring the AI Compute Market
• 3 Top Financial Institutions Announce Over $70 Billion in Share Repurchases
• Rezolve AI Stock Has a Short-Squeeze Setup, But Execution Comes First
• SpaceX Achieves Escape Velocity With Nasdaq Fast-Track

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.